The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. ...
Apr 5, 2012
0
0
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. ...
Sep 21, 2022
0
2
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup ...
Feb 9, 2012
0
0
(HealthDay)—There's another alarming consequence to America's heroin and prescription painkiller epidemic: an increase in a serious heart infection called endocarditis, U.S. health officials report.
Jun 8, 2017
0
0
In a breakthrough study published online today in The Lancet, researchers from Boston University, Save the Children and the WHO found that young children treated at home for severe pneumonia by Pakistan's network of "lady ...
Nov 10, 2011
0
0
Pakistan said on Sunday over 600 people, most of them children, had tested HIV positive in a city in the southern Sindh province.
May 26, 2019
0
2
Investigators at Nationwide Children's have received a grant from the National Institutes of Health (NIH) to help move a therapy for MPS IIIB that has been shown effective in mice toward clinical trials in humans.
May 25, 2011
0
0
Researchers at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and collaborators from the School of Basic Medical Sciences, Fudan University, Shanghai, have developed an 'intravenous injection plus light-triggered ...
Aug 30, 2021
0
230
HIV-related deaths last year fell to around 770,000—some 33 percent lower than in 2010—the United Nations said Tuesday, but warned that global efforts to eradicate the disease were stalling as funding dries up.
Jul 16, 2019
0
1
(HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.
Dec 21, 2012
1
0
